Baird Maintains Neutral on HCA Healthcare, Lowers Price Target to $393
HCA Healthcare Inc
HCA Healthcare Inc HCA | 0.00 |
Baird analyst Michael Ha maintains HCA Healthcare (NYSE:
HCA) with a Neutral and lowers the price target from $396 to $393.
